Image Source: AsiaOne
Junshi Biosciences Announces Approval of “B” Marker Removal from Company’s Stock Name by HKEXGlobeNewswireJuly 12, 2020SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong Limited (HKEX) pursuant to Rule 18A.12 of the Rules Governing the Listing of Securities on HKEX (Listing Rules), HKEX has granted approval for the dis-application of Rules 18A.09 to 18A.11 of the Listing Rules. Junshi Biosciences originally listed on the HKEX on December 24, 2018 under Chapter 18 A (the biotech chapter) of the Listing Rules. It now satisfies and even well surpasses the revenue and market capitalization requirements for the dis-application. As a result of the approval by the HKEX, the “B” marker will no longer be affixed to the Company’s stock name in the HKEX. About Junshi Biosciences
Source: AsiaOne